Ftse Mib
33.739,90
-0,08%
DAX
19.848,77
-0,34%
S&P 500
6.040,04
1,10%
NASDAQ
20.031,13
1,35%
Bitcoin
99.227,02
-0,08%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ 180 Life Sciences Corporation (ATNF) 180 Life Sciences Corporation (ATNF) Notizie

180 Life Sciences Corporation

ATNF
2,90
1,03 (55,08%)
24 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
25/10/202415:00GLOBEElray Resources Announces Strategic Sale of Crypto iGaming..
12/9/202422:15GLOBE180 Life Sciences Announces the Appointment of Omar Jimenez..
12/8/202423:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
30/7/202414:00EDGAR2Form 8-K - Current report
30/7/202414:00GLOBE180 Life Sciences Announces Positive Topline Results of a..
23/7/202414:00EDGAR2Form 8-K - Current report
23/7/202414:00GLOBE180 Life Sciences Granted an Additional Extension by Nasdaq..
19/7/202422:15EDGAR2Form S-1 - General form for registration of securities under..
02/7/202414:30GLOBE180 Life Sciences Granted Extension by Nasdaq Hearing Panel..
14/3/202413:30GLOBE180 Life Sciences Regains Full Compliance with Nasdaq ..
11/3/202412:03EDGAR2Form 8-K - Current report
08/3/202422:49EDGAR2Form 8-K - Current report
29/2/202414:00EDGAR2Form 8-K - Current report
28/2/202412:42EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
28/2/202412:39EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
28/2/202412:37EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
28/2/202412:30EDGAR2Form 8-K - Current report
26/2/202413:00EDGAR2Form 8-K - Current report
26/2/202413:00GLOBE180 Life Sciences Corp. Announces 1-For 19 Reverse Stock..
20/2/202414:01EDGAR2Form 8-K - Current report
16/2/202423:10EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
16/2/202423:08EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
16/2/202423:05EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
16/2/202422:15EDGAR2Form 8-K - Current report
12/2/202422:15EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
31/1/202423:29EDGAR2Form S-1 - General form for registration of securities under..
29/1/202414:00EDGAR2Form 8-K - Current report
17/1/202414:30EDGAR2Form 8-K - Current report
16/1/202414:30EDGAR2Form 8-K - Current report
29/12/202300:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/12/202322:15EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
Apertura: 2,66 Min: 2,13 Max: 3,19
Chiusura: 1,87

La tua Cronologia

NASDAQ
ATNF
180 Life Sciences
LSE
44RN
Lloyds Bk. 46
LSE
38MA
Lloyds Bk. 29
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network